VR-Based Behavioral Activation in Adults
VR-Dep
Behavioural Activation Intervention for Depression in a Virtual Reality Environment: Software Development and Effectiveness Study
2 other identifiers
interventional
50
1 country
1
Brief Summary
Study Overview This study aims to evaluate the effectiveness of a newly developed Virtual Reality (VR) behavioral activation software program for individuals experiencing symptoms of depression. Behavioral activation is a well-established psychological approach that helps individuals re-engage in positive, rewarding activities to reduce depressive symptoms and improve mood. By translating this approach into an immersive VR environment using hand-tracking technology, the study explores whether technology-enhanced interventions can make therapy more accessible, engaging, and effective. What the Study InvolvesParticipants in this study are randomly assigned to one of two groups:VR Behavioral Activation Group (Intervention): Participants in this group receive a structured behavioral activation program delivered entirely within a customized virtual reality environment. Using advanced hand-tracking technology instead of traditional controllers, participants interact naturally with the virtual world to complete rewarding tasks and activities designed to boost engagement and mood. Waitlist Control Group: Participants in this group do not receive the VR intervention during the active study period, serving as a comparison baseline to accurately measure the specific effects of the VR software. However, to ensure ethical standards and support all participants, individuals in this group receive psychological education (psychoeducation) after the data collection phase is fully completed. Research Goals The primary goal is to determine if the VR-focused behavioral activation program successfully reduces depression severity and enhances overall behavioral activation levels compared to the control group. Additionally, researchers will evaluate how the intervention influences the body's behavioral approach and inhibition systems, providing insights into the underlying psychological mechanisms of VR-driven therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 4, 2026
CompletedFirst Posted
Study publicly available on registry
July 14, 2026
CompletedJuly 14, 2026
July 1, 2026
10 months
July 4, 2026
July 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Beck Depression Inventory (BDI) Scores
The BDI is a 21-item self-report questionnaire used to measure the severity of depressive symptoms. Each item is rated on a 4-point scale ranging from 0 to 3. Total scores range from 0 to 63, with higher scores indicating more severe depressive symptoms.
Baseline (Pre-test) and Post-test (Week 4)
Study Arms (2)
VR Behavioral Activation Group
EXPERIMENTALParticipants in this group receive a structured behavioral activation program delivered entirely within a customized virtual reality environment using hand-tracking technology to reduce depressive symptoms and enhance behavioral activation.
Waitlist Control Group
OTHERParticipants in this group serve as a comparison baseline and do not receive the VR intervention during the active study period. After all post-test data collection is completed, they are provided with a psychological education (psychoeducation) program for ethical support.
Interventions
A customized virtual reality (VR) software application developed for Meta Quest hardware, utilizing hand-tracking technology. The software delivers a structured behavioral activation program designed to treat depressive symptoms by engaging participants in immersive, therapeutic activities.
Participants remain on a waitlist during the active implementation phase to serve as a control group. Upon completion of all post-test data collection, they receive a comprehensive psychological education (psychoeducation) program to ensure ethical treatment standards.
Eligibility Criteria
You may qualify if:
- Being 18 years of age or older.
- Being literate (ability to read and write).
- Providing written informed consent by reading and signing the informed consent form.
- Having a score of 17 or above on the Beck Depression Inventory (BDI).
- Having a score of 41 or below on the Behavioral Activation subscale of the Behavioral Inhibition System and Behavioral Activation System (BIS/BAS) Scale.
- Having a score of 21 or above on the Behavioral Inhibition subscale of the Behavioral Inhibition System and Behavioral Activation System (BIS/BAS) Scale.
You may not qualify if:
- Having advanced vision problems that impair visual function, such as cataracts.
- Having uncorrected visual impairments, such as color blindness.
- Having any psychiatric or neurological disorder characterized by impaired reality testing.
- Being under 18 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aydin Adnan Menderes University, Department of Psychology
Aydin, 09010, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mehmet Şakiroğlu, Assoc. Prof.
Aydin Adnan Menderes University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2026
First Posted
July 14, 2026
Study Start
December 10, 2024
Primary Completion
September 22, 2025
Study Completion
November 1, 2025
Last Updated
July 14, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share